Section 20 — Medicines management
Abstract
Section 20 — Medicines management SAGE Publications, Inc.2007DOI: 10.1177/10781552070130030121 20.1 Procedures for drug selection 20.1.1 Medication selection Medication selection should be a multidisciplinary process, overseen by the respective institution's Pharmacy and Therapeutics Committee (P&T Committee) or other appropriate group. The process should involve medical staff (oncologist/haematolo- gist), pharmacists, nursing and administrative staff. 20.1.2 Documentation – P&T committee Written policies and procedures should be developed and implemented to define the functioning of the P&T committee or other appropriate group. 20.1.3 Documentation – medication selection Written policies and procedures about the process of medication selection in an institution should be developed, approved and implemented, that include: (a) How to request additions, changes or dele- tions to/from the formulary (b) Evaluation process (c) Dissemination of information about P&T Committee decisions (d) Mechanism for updating the formulary or list (at least annually based on emerging information). 20.1.4 Criteria for medication selection Medication selection should be based on safety, cost- effectiveness, and/or any pharmacotherapy innova- tion (for example, easier route of administration, reduced dosing frequency). Comparison should be made with alternatives already available at the institution. 20.1.5 Criteria for request(s) Qualitative and/or quantitative criteria should be developed and implemented to evaluate the request,